| Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells S Matsuyama, N Nao, K Shirato, M Kawase, S Saito, I Takayama, ... Proceedings of the National Academy of Sciences 117 (13), 7001-7003, 2020 | 1418 | 2020 |
| Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development M Imai, K Iwatsuki-Horimoto, M Hatta, S Loeber, PJ Halfmann, ... Proceedings of the National Academy of Sciences 117 (28), 16587-16595, 2020 | 992 | 2020 |
| Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2 S Matsuyama, N Nagata, K Shirato, M Kawase, M Takeda, F Taguchi Journal of virology 84 (24), 12658-12664, 2010 | 889 | 2010 |
| TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection N Iwata-Yoshikawa, T Okamura, Y Shimizu, H Hasegawa, M Takeda, ... Journal of virology 93 (6), 10.1128/jvi. 01815-18, 2019 | 689 | 2019 |
| Transmission of SARS-CoV-2 in domestic cats PJ Halfmann, M Hatta, S Chiba, T Maemura, S Fan, M Takeda, ... New England Journal of Medicine 383 (6), 592-594, 2020 | 558 | 2020 |
| Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion M Takeda, GP Leser, CJ Russell, RA Lamb Proceedings of the National Academy of Sciences 100 (25), 14610-14617, 2003 | 471 | 2003 |
| Development of genetic diagnostic methods for detection for novel coronavirus 2019 (nCoV-2019) in Japan K Shirato, N Nao, H Katano, I Takayama, S Saito, F Kato, H Katoh, ... Japanese journal of infectious diseases 73 (4), 304-307, 2020 | 442 | 2020 |
| Identification of nafamostat as a potent inhibitor of Middle East respiratory syndrome coronavirus S protein-mediated membrane fusion using the split-protein-based cell-cell … M Yamamoto, S Matsuyama, X Li, M Takeda, Y Kawaguchi, J Inoue, ... Antimicrobial agents and chemotherapy 60 (11), 6532-6539, 2016 | 381 | 2016 |
| Efficacy of antibodies and antiviral drugs against Covid-19 Omicron variant E Takashita, N Kinoshita, S Yamayoshi, Y Sakai-Tagawa, S Fujisaki, M Ito, ... New England Journal of Medicine 386 (10), 995-998, 2022 | 362 | 2022 |
| Global distribution of measles genotypes and measles molecular epidemiology PA Rota, K Brown, A Mankertz, S Santibanez, S Shulga, CP Muller, ... The Journal of infectious diseases 204 (suppl_1), S514-S523, 2011 | 327 | 2011 |
| Measles virus: cellular receptors, tropism and pathogenesis Y Yanagi, M Takeda, S Ohno Journal of General Virology 87 (10), 2767-2779, 2006 | 325 | 2006 |
| Influenza A Virus M2 Ion Channel Activity Is Essential for Efficient Replication in Tissue Culture M Takeda, A Pekosz, K Shuck, LH Pinto, RA Lamb Journal of virology 76 (3), 1391-1399, 2002 | 320 | 2002 |
| Efficacy of antiviral agents against the SARS-CoV-2 omicron subvariant BA. 2 E Takashita, N Kinoshita, S Yamayoshi, Y Sakai-Tagawa, S Fujisaki, M Ito, ... New England Journal of Medicine 386 (15), 1475-1477, 2022 | 285 | 2022 |
| Proteolytic activation of the 1918 influenza virus hemagglutinin C Chaipan, D Kobasa, S Bertram, I Glowacka, I Steffen, ... Journal of virology 83 (7), 3200-3211, 2009 | 275 | 2009 |
| Crystal structure of measles virus hemagglutinin provides insight into effective vaccines T Hashiguchi, M Kajikawa, N Maita, M Takeda, K Kuroki, K Sasaki, ... Proceedings of the National Academy of Sciences 104 (49), 19535-19540, 2007 | 264 | 2007 |
| SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein K Hashimoto, N Ono, H Tatsuo, H Minagawa, M Takeda, K Takeuchi, ... Journal of virology 76 (13), 6743-6749, 2002 | 262 | 2002 |
| Mitofusin 2 inhibits mitochondrial antiviral signaling K Yasukawa, H Oshiumi, M Takeda, N Ishihara, Y Yanagi, T Seya, ... Science signaling 2 (84), ra47-ra47, 2009 | 256 | 2009 |
| Measles virus V protein blocks interferon (IFN)-α/β but not IFN-γ signaling by inhibiting STAT1 and STAT2 phosphorylation K Takeuchi, S Kadota, M Takeda, N Miyajima, K Nagata FEBS letters 545 (2-3), 177-182, 2003 | 247 | 2003 |
| The anticoagulant nafamostat potently inhibits SARS-CoV-2 S protein-mediated fusion in a cell fusion assay system and viral infection in vitro in a cell-type-dependent manner M Yamamoto, M Kiso, Y Sakai-Tagawa, K Iwatsuki-Horimoto, M Imai, ... Viruses 12 (6), 629, 2020 | 245 | 2020 |
| Recovery of pathogenic measles virus from cloned cDNA M Takeda, K Takeuchi, N Miyajima, F Kobune, Y Ami, N Nagata, Y Suzaki, ... Journal of virology 74 (14), 6643-6647, 2000 | 195 | 2000 |
